Company Overview
About SFA Therapeutics
SFA Therapeutics is a Philadelphia-based clinical-stage biotech developing oral small molecule drugs that modulate regulatory T cells (Tregs) — the immune system's natural suppressor cells — to restore immune homeostasis in autoimmune diseases and cancer without the broad immunosuppression that existing biologics and small molecule therapies cause. The company raised $9.13 million from investors including Savantus Ventures and Ben Franklin Technology Partners, announced positive Phase 1b safety data for SFA-002 in psoriasis in March 2025, and received a 2025 Prix Galien USA Best Startup award nomination.
Business Model & Competitive Advantage
SFA Therapeutics' Treg modulator approach targets a fundamentally different mechanism than approved autoimmune drugs: rather than blocking specific inflammatory cytokines (like TNF inhibitors) or broadly depleting immune cells (like many chemotherapy agents), SFA-002 and related compounds selectively increase the activity or number of Tregs — the cells that naturally regulate immune responses and prevent autoimmunity. This "restore natural balance" mechanism could potentially treat autoimmune diseases while preserving normal immune function more completely than current approaches.
Competitive Landscape 2025–2026
In 2025, SFA competes in the autoimmune drug discovery and Treg biology space with Sonoma Biotherapeutics, Quell Therapeutics (Treg cell therapy), Cue Biopharma (Treg-stimulating biologics), and the established small molecule immunology companies (AbbVie with Humira/Skyrizi, Pfizer with Xeljanz) for autoimmune disease treatment. The Treg biology field has generated significant scientific interest — if oral small molecules can selectively activate Tregs without causing immunosuppression or infection risk, the therapeutic window for autoimmune diseases could be dramatically expanded. Psoriasis Phase 1b safety data is the first human clinical validation of the approach. The 2025 strategy focuses on advancing SFA-002 through Phase 2 proof-of-concept trials in psoriasis, exploring additional autoimmune indications (rheumatoid arthritis, inflammatory bowel disease), and building the chemistry platform for next-generation Treg modulators.
Recent Activity
View all →Key Differentiators
Emerging Innovator
SFA Therapeutics is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Browser Use
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
Compare SFA Therapeutics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from SFA Therapeutics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim SFA Therapeutics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention SFA Therapeutics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →